This review critically examines the molecular and clinical spectrum of GBA1 -associated PD, highlighting the relationship between variant severity, lysosomal dysfunction, and disease progression, and summarizes emerging disease-modifying therapeutic strategies, including small-molecule GCase activators, pharmacological...
Christiane Oleksy, I. Boussaad, Z. Landoulsi et al.· npj Parkinson's Disease· 0 citations
We use cookies to run the site and, with your consent, for analytics and to show ads.
See our Cookie Policy.